Aptevo Therapeutics Inc. shares surged nearly 50% early Thursday on promising leukemia trial results, before paring gains in ...

Study reveals how socioeconomic factors create barriers to bone marrow transplants for AML patients in disadvantaged ...

By Nancy Lapid (Reuters) - Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, ...

Carla Harris has been diagnosed with and beaten acute myeloid leukemia thanks to a bone marrow transplant from her sister, ...

Patients with acute myeloid leukemia who have lower education levels and lower income are less likely to receive an ...

A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...

Conventional parameters for risk stratification prognosis for patients with low-risk myelodysplastic neoplasms, especially ...

Researchers at University of California San Diego School of Medicine and their colleagues have developed the first ...

A 14-year-old Marshfield freshman was surprised earlier today when a special guest visited the Children’s Mercy Hospital, ...

Aptose Biosciences (APTO) announced the publication of preclinical data for Aptose’s lead hematology compound tuspetinib in Cancer Research ...

Irwin Cecil Tindall of Fort Hall Idaho started his journey to the other side early on Saturday, December 7, 2024. The wake ...

(RTTNews) - Moleculin Biotech, Inc. (MBRX), Wednesday announced the preliminary activity of Annamycin in heavily pretreated, relapsed/refractory acute myeloid leukemia or AML patients who had ...